ketanserin has been researched along with Hypertrophy, Left Ventricular in 3 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
Hypertrophy, Left Ventricular: Enlargement of the LEFT VENTRICLE of the heart. This increase in ventricular mass is attributed to sustained abnormal pressure or volume loads and is a contributor to cardiovascular morbidity and mortality.
| Excerpt | Relevance | Reference |
|---|---|---|
| "05) but not with L-arginine compared to untreated coronary arteries from left ventricular hypertrophy animals." | 3.72 | Tetrahydrobiopterin and antioxidants reverse the coronary endothelial dysfunction associated with left ventricular hypertrophy in a porcine model. ( Carrier, M; Desjardins, F; Malo, O; Perrault, LP; Tanguay, JF; Tardif, JC, 2003) |
| "Ketanserin is an anti-hypertensive drug with an ability to reduce blood pressure variability (BPV) in acute experiments in spontaneously hypertensive rats (SHRs)." | 1.32 | Effects of long-term treatment with ketanserin on blood pressure variability and end-organ damage in spontaneously hypertensive rats. ( Du, WM; Liu, JG; Miao, CY; Shen, FM; Su, DF; Yang, XQ, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, WM | 1 |
| Miao, CY | 1 |
| Liu, JG | 1 |
| Shen, FM | 1 |
| Yang, XQ | 1 |
| Su, DF | 1 |
| Malo, O | 1 |
| Desjardins, F | 1 |
| Tanguay, JF | 1 |
| Tardif, JC | 1 |
| Carrier, M | 1 |
| Perrault, LP | 1 |
| Deuchar, GA | 1 |
| Hicks, MN | 1 |
| MacLean, MR | 1 |
3 other studies available for ketanserin and Hypertrophy, Left Ventricular
| Article | Year |
|---|---|
Effects of long-term treatment with ketanserin on blood pressure variability and end-organ damage in spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Female; Hypertension; Hypertrophy, Left Ventricular; Ketanserin; Kidney Fai | 2003 |
Tetrahydrobiopterin and antioxidants reverse the coronary endothelial dysfunction associated with left ventricular hypertrophy in a porcine model.
Topics: Animals; Antioxidants; Arginine; Biomarkers; Bradykinin; Catalase; Coronary Vessels; Dose-Response R | 2003 |
The role of 5-hydroxytryptamine in the control of pulmonary vascular tone in a rabbit model of pulmonary hypertension secondary to left ventricular dysfunction.
Topics: Animals; Aorta; Blood Pressure; Cardiac Output; Disease Models, Animal; Heart Rate; Hypertension, Pu | 2005 |